I'm a trainee  <a href="http://barlens.com.au/lovastatin-drugscom-72f7.pdf#hinder">lovastatin drugs.com
</a>  Under a separate pathway known as "accelerated approval" drugs may be approved based on a so-called surrogate endpoint - a measure, such as tumor shrinkage - that might reasonably be expected to confer a clinical benefit such as improved survival.